NKP46-BINDENDE MITTEL

European patent · EP3574016 · In force

Register entry

Publication number
EP3574016
Application number
EP18703224
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 22, 2018
Published
Dec 4, 2019
Granted
Jul 23, 2025
Protection ends at the latest
Jan 21, 2038
Next annual fee due
Jan 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
US 201762449617 P 24.01.2017
US 201762530443 P 10.07.2017
PCT application
PCT/EP2018/051394 22.01.2018
PCT publication
WO2018/138032 02.08.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 4, 2026

    Change

    Published in Swissreg on 04.06.2026

  2. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  3. Jul 23, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 23.07.2025

Parties

Holder

Innate Pharma

117, Avenue de Luminy, 13009 Marseille, FR

Inventor

ANCERIZ, Nadia

13400 Aubagne, FR

BLERY, Mathieu

13009 Marseille, FR

GAUTHIER, Laurent

13008 Marseille, FR

PATUREL, Carine

69280 Marcy l'Etoile, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.